Endpoints News 26. März 2026 Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 program
Endpoints News 26. März 2026 Oral peptides biotech Pinnacle Medicines gets $89M from US, China investors
Endpoints News 25. März 2026 After tumultuous year, Sarepta plots rebound with early data on RNA therapies
Endpoints News 25. März 2026 Beam looks to accelerated approval for AATD base editing after promising update
Endpoints News 25. März 2026 Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Endpoints News 25. März 2026 Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
Endpoints News 25. März 2026 Microneedle vaccine patch company raises $50M for pivot to GLP-1 delivery
Endpoints News 25. März 2026 Maze meets own expectations in Phase 2 kidney disease trial in the same arena as Vertex
Endpoints News 25. März 2026 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix